Previous Article | Next Article ![]()
Journal of Virology, May 2002, p. 4591-4602, Vol. 76, No. 9
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.9.4591-4602.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
INSERM U 538, CHU Saint Antoine, Université Pierre et Marie Curie, 75012 Paris,1 Virologie Moléculaire et Cellulaire, INRA, 78352 Jouy en Josas, France2
Received 1 October 2001/ Accepted 22 January 2002
|
|
|---|
|
|
|---|
Rotavirus, a triple-layered nonenveloped virus (70), is a worldwide cause of infantile gastroenteritis, accounting for an estimated 600,000 deaths annually (2). Knowledge of the detailed process of virus assembly is required to provide a molecular basis for the design of drugs or strategies able to interfere with virus entry, assembly, and/or replication. The interest in this approach has been enhanced since the withdrawal of the tetravalent vaccine because of side effects (7). In vivo rotavirus specifically targets highly polarized intestinal cells (59). This prompted us to develop studies on rotavirus infection of Caco-2 cells (17), which originate from human colon and which display a well-polarized and differentiated enterocytic phenotype when grown in culture (11). We demonstrated earlier that rotavirus was secreted before any significant cell lysis in a highly polarized way to the apical sides of Caco-2 cells. We also observed that virus apical secretion followed an atypical route through vesicular traffic bypassing the Golgi apparatus (30). Together, these results address the question of the precise mechanisms and localization of rotavirus assembly in these cells.
The widely accepted model for rotavirus assembly (14) was deduced from studies performed essentially with MA 104 cells, a poorly differentiated cell line originating from monkey kidney epithelium (67). The model may be summarized as follow. After solubilization of the outer capsid layer, the translation of structural and nonstructural proteins takes place in the host cell cytoplasm. A subset of structural proteins, namely, VP1, VP2, VP3, and VP6, assemble in the viroplasm, an ill-defined structure from which double-layered particles (DLP) that contain the double-stranded RNA emerge. The next step includes the translocation of DLP across the endoplasmic reticulum (ER) membrane and the formation of a transient envelope around the viral particles inside the ER lumen (49). Entry of DLP into the ER lumen is likely to be driven by specific interactions between VP6 on the DLP and the cytoplasmic domain of NSP4 (63). Exit of virus from the ER and assembly with VP7 and VP4 are less documented and involve a ternary complex containing NSP4, VP7, and VP4 (36, 60). NSP4 and VP7 are two integral transmembrane proteins tightly associated with the ER membrane (9, 50). VP7 has also been shown outside the ER in punctate structures that likely correspond to accumulated virus particles and in regions of the ER surrounding the viroplasm (31). NSP4 has also been recently identified along microtubule-like structures (69).
The present knowledge of VP4 localization is much less clear. Based on conventional electron-microscopic studies it has been assumed that VP4 may be present as a fine reticular material associated with VP7 and NSP4 at the junction area of the ER membrane and virus particles (60). However no obvious evidence that VP4 is in the transiently enveloped immature virus that has been observed in the ER or in any other location within the ER has been provided so far (22). Therefore it is difficult to reconcile the hypothesis of a complete intrareticular assembly of rotavirus with an exclusive extrareticular localization for VP4. Indeed, we recently showed that, early after MA 104 cell infection, VP4 was not localized within the ER but was associated with the plasma membrane, intracellular vesicles, and microtubules. Interestingly, this localization was also observed in MA 104 cells transfected with a VP4 plasmid, suggesting that VP4 targeting depends on signals present on the protein rather than on virus particles (46).
From the above data, it appears that a better knowledge of VP4 localization and targeting in polarized Caco-2 cells should provide key information on rotavirus assembly and polarized secretion. Since a previous study of ours indicates that virus particles are targeted to the apical side of the cells (30), we hypothesized that virus interacts, at least to some extent, with the apical targeting machinery of Caco-2 cells. It has been recently proposed that rafts play a pivotal role in apical sorting and targeting in polarized cells (58). Rafts have been defined by their insolubility in Triton X-100 detergent (6, 35) due to their high proportion of cholesterol, sphingolipids, and/or glycosphingolipids. It has been shown that, in Caco-2 cells, rafts are involved in the apical targeting of glycosylphosphatidylinositol (GPI)-anchored glycoproteins such as alkaline phosphatase (AP) and of some transmembrane glycoproteins such as sucrase-isomaltase (SI) but not of dipeptidyl peptidase IV (DPP IV), another apically targeted hydrolase (1, 20).
In the present study we have undertaken an extensive analysis of VP4 localization and targeting in Caco-2 cells following rotavirus infection. We searched for a putative association of VP4 with rafts. Our rationale for such an approach was based (i) on the apical targeting of viral particles in Caco-2 cells; (ii) on the observation that, in rotavirus-infected Caco-2 cells, SI targeting is impaired whereas DPP IV targeting is mostly unaffected (29); and (iii) on data indicating that rotavirus may interact with glycosphingolipids (12) highly enriched in rafts, as well as with some raft proteins (23). We found that VP4 associates with rafts within the cells as early as 3 h postinfection (p.i.), a phenomenon concomitant with an early apical targeting of VP4 to rafts located at the apical membrane of Caco-2 cells. Later on, other structural proteins also became associated with rafts, a process that leads to the assembly of mature rotavirus. These results indicate that VP4 drives the assembly of rotavirus particles by using rafts as a platform. Such a proposal implies that the final step of rotavirus assembly should take place in an extrareticular compartment, thus leading to a new model for rotavirus assembly that is the first example of the implication of rafts in the intracellular handling of a nonenveloped virus.
|
|
|---|
Transfection. Caco-2 cells were transfected with a supercoiled DNA plasmid encoding VP4-green fluorescent protein (GFP) (46). Transfections were performed using FuGENE 6 (Roche Diagnostics, Meylan, France) according to the manufacturer's instructions. Briefly, Caco-2 cells were seeded in six-well plates (105 per well). Two days later, transfection was performed at around 60% confluence. Cells were washed twice with OptiMEM. Five micrograms of supercoiled DNA was gently mixed with 12.5 µl of transfection reagent in 1 ml of OptiMEM (Life Technologies). Cells were transfected for 6 h, washed three times, and observed within 48 h posttransfection.
DRM preparation. Detergent-resistant membranes (DRM) were prepared on ice as follows. Cells were washed twice with phosphate-buffered saline (PBS), scraped in TNE buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, and a mixture of antiproteases: 4 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride [AEBSF] and 25 µg of benzamidine, 10 mg of aprotinin, 10 µg of antipain, 10 µg of leupeptin, and 10 µg of pepstatin/ml) containing 1% Triton X-100, passed 10 times through a 22-gauge needle, and kept at 4°C for 30 min. Triton X-100-treated homogenates were then mixed with sucrose or OptiPrep (Sigma-Aldrich, St. Quentin Fallavier, France) such that density reached 40%. DRM were separated from detergent-solubilized membranes and from soluble proteins by ultracentrifugation either on a discontinuous (40, 35, and 5%) sucrose gradient (180,000 x g for 18 h at 4°C in a Beckman SW 41 rotor) or on a discontinuous (40, 30, and 5%) OptiPrep gradient (100,000 x g for 4 h at 4°C in the same rotor). In both protocols, DRM were recovered in fractions 4 and 5 at the interface of the 5% layer with the 30 or 35% layer. After vigorous mixing, the 40% layer was considered the soluble fraction. Triton X-100 homogenates were sonicated before being analyzed.
Lipid analysis. Lipids from DRM and whole-cell homogenates were extracted in chloroform-methanol following phase separation as described by Bligh and Dyer (4). Solvents were removed under a stream of nitrogen, and the lipids were resuspended in chloroform-methanol (1:1 [vol/vol]). Total phospholipids were determined on crude lipid extract by measurement of phosphorus content. Separation of the main classes of phospholipids was achieved by thin-layer chromatography (TLC) in chloroform-methanol-water (65:25:4 [vol/vol]). Sphingomyelin was scraped from the plate and assayed for phosphorus content. For cholesterol determination, an aliquot of lipid extract was evaporated and redissolved in ethanol. Cholesterol content was determined by a colorimetric assay (19).
HPLC analysis of phospholipid molecular species. Total phospholipids were separated from neutral lipids by loading lipid extracts on TLC plates and developing them in petroleum ether-ethyl ether-acetic acid (70:30:1 [vol/vol/vol]). Phospholipids were scraped from the plate, extracted from silica gel, and hydrolyzed by phospholipase C from Bacillus cereus (Sigma-Aldrich), and the diglycerides obtained were converted to benzoylated derivatives (3). These derivatives absorb at 230 nm, and the absorption is proportional to their amounts. After purification by TLC, the molecular species were analyzed by reverse-phase high-pressure liquid chromatography (HPLC; acetonitrile-propanol-2 [75/25 {vol/vol}]), and peaks were visualized by absorption at 230 nm as already described (38).
Antibodies. A rabbit polyclonal anti-RF antiserum (8148) that recognized VP2, VP4, VP6, and VP7 was diluted 1:400 for immunofluorescence (IF) and 1:3,000 for Western blot (WB) analysis. A mouse monoclonal anti-VP4 antibody (7.7) that is directed against VP8* and that also recognizes VP4 in mature virus was used at 1:200 (IF) or 1:1,000 (WB) (46). A mouse monoclonal anti-VP2 antibody (164E22) was used at 1:1,000 (52). A rabbit polyclonal antibody raised against NSP4 (1:1,000) was a gift from J. Taylor (Auckland, New Zealand). A rat monoclonal anti-human DPP IV (1:200) was a gift from S. Maroux (Marseille, France). A mouse monoclonal anti-human SI (1:200) was a gift from H.-P. Hauri (Basel, Switzerland). A mouse monoclonal anti-human AP (clone 8B6; 1:300 for IF and 1:1,000 for WB) was purchased from Sigma-Aldrich. Fluorescein-conjugated donkey anti-rabbit immunoglobulin G (IgG), donkey anti-mouse IgG, and donkey anti-rat IgG (Jackson Laboratories, Interchim, Montluçon, France) were used at 1:200. Peroxidase-conjugated donkey anti-rabbit IgG and anti-mouse IgG (Pierce, Interchim) were used at 1:15,000.
IF and confocal microscopy. Caco-2 cells, grown either on glass coverslips or on filters, were washed three times with cold PBS and then fixed with 2% paraformaldehyde (PFA) for 20 min at room temperature. All the subsequent steps were carried out in the presence of 50 mM NH4Cl to quench free aldehyde groups. When indicated, cells were permeabilized with saponin (0.075%). Saponin was added in all the subsequent solutions. Permeabilized and nonpermeabilized cells were incubated with the primary antibody for 45 min at room temperature. After three washes with PBS, the second fluorescence-labeled antibody was incubated for 30 min at room temperature. Cells were washed five times with PBS and, in some experiments, incubated with 1 mg of RNase A/ml for 10 min and with propidium iodide (1 µg/ml) for 3 min to visualize nuclei. Samples were treated with 100 mg of diazabicyclo[2.2.2.]octane (DABCO; Sigma-Aldrich)/ml and mounted with Glycergel (Dako SA, Trappes, France). Fluorescence was observed with a Leica TCS Spectral (SP1) equipped with a DMR inverted microscope and 63x and 40x objectives, both with a numerical aperture of 1.4. A krypton-argon mixed-gas laser was used to generate two bands: 488 nm for fluorescein isothiocyanate (FITC) and 568 nm for propidium iodide. Image processing was performed using the on-line Scan Ware software. Numeric images, stored on compact disk, were treated and mounted on an image analysis station (Scion Image and Photoshop, version 5.1).
WB analysis. After trichloroacetic acid (TCA) precipitation, proteins recovered from gradients were separated by sodium dodecyl sulfate-7.5 or 10% polyacrylamide gel electrophoresis together with molecular weight standards (Amersham Pharmacia Biotech, Saclay, France) and transferred onto nitrocellulose (Hybond-C; Amersham). Nonspecific staining was prevented by 2 h of incubation in a polyvinylpyrrolidone (PVP) solution (1% PVP, 0.05% Tween 20 in PBS). Nitrocellulose sheets were incubated with a primary antibody for 1 h at room temperature. After five washes with PBS-Tween 20, the second antibody was added for 1 h at room temperature. After five washes, the ECL reagent (Amersham) and Biomax-Light 1 films (Kodak, Sigma-Aldrich) were used to reveal proteins. Films were scanned with a densitometric scanner (Agfa), and bands were quantified with Scion Image software.
X-ray diffraction analysis. The small-angle scattering data were recorded at station 8.2 of SRS Daresbury Laboratory (Warrington, United Kingdom; beam time EC allocation 36039). Twenty milligrams of lipids, obtained from Sigma-Aldrich, was fully hydrated (>1/1 [wt/wt]) with an aqueous buffer (10 mM Tris-HCl, pH 8.0) containing calcium in a 1/1,000 to 1/100 molar ratio with lipid. The virus particles (20 mg of purified trypsinized virus particles/ml) (18) or the viral protein (1 mg of purified VP4/ml recovered after expression in Escherichia coli as a fusion protein with a His tag using plasmid vector pET-28b(+) from Novagen [Tebu, Le Perray en Yvelines, France] and purified with chelating Sepharose-nickel from Amersham) was mixed with lipids during the hydration step. To insure a homogeneous hydration, the sample was sealed under argon for at least a week before X-ray examination. The camera length was set to 2.5 m. The response of the quadrant detector was recorded with radioactive source 59Fe, allowing the normalization of scattering records for the channel response (1,024 channels/frame). The temperature was varied linearly with a programmable stage (Linkham) during the measurement. The data were processed with Otoko software kindly provided by M. Koch (5).
|
|
|---|
![]() View larger version (72K): [in a new window] |
FIG. 1. Early after rotavirus infection, VP4 is expressed at the apical membrane of Caco-2 cells and in discrete intracellular locations. Caco-2 cells (21 days old), grown on Transwell filters, were infected with the RF rotavirus strain at 10 PFU/cell (A to E). Six hours p.i., cells were fixed with 2% PFA and not permeabilized (A to C) or permeabilized (D and E). VP4 was detected using monoclonal antibody 7.7 and a FITC-labeled secondary anti-mouse IgG antibody. Nuclei were labeled with propidium iodide (red channel). (A) General representative view of the sum of the five most apical sections (1 µm deep each). (B) xy projection on a zoomed view. Ten 0.5-µm-thick sections were recorded from the top to the bottom and were projected on one plane to recover all the data available in the sample. (C) xz section obtained through an xz direct scanning procedure. (D and E) In permeabilized cells, it was possible to show that VP4 localized to discrete locations that evoked vesicular and tubular structures, which are illustrated as 1-µm-thick sections through the middle of the cells. (F) Cells were transiently transfected with VP4-GFP, as described in Materials and Methods, and directly observed with the confocal microscope within 48 h posttransfection. A sum of 15 sections, each 0.5 µm thick, is displayed. Bars = 10 µm.
|
![]() View larger version (68K): [in a new window] |
FIG. 2. Apically expressed VP4 resists Triton X-100 extraction. Caco-2 cells (21 days old), grown on glass coverslips, were infected with the RF rotavirus strain at 10 PFU/cell. Six hours p.i., cells were extracted with Triton X-100 on ice for 1 to 2 min, fixed with 2% PFA, and analyzed by indirect IF and confocal microscopy for the presence of proteins that do or do not resist detergent extraction. SI (A to D) and AP (E and F) were selected as positive controls, and DPP IV (G to J) was used as a negative control. VP4 (K to N ) was revealed using monoclonal antibody 7.7. Twenty-five 0.5-µm-thick sections were recorded and combined (projection) to obtain an xy representation of SI (A and C), AP (E and F), DPP IV (G and I), and VP4 (K and M). xz sections were obtained through an xz direct-scanning procedure for SI (B and D), DPP IV (H and J), and VP4 (L and N). Panels A, B, E, G, H, K, and L were obtained in the absence of Triton X-100, whereas panels C, D, F, I, J, M, and N were recorded after Triton X-100 extraction. Bars, 10 µm.
|
![]() View larger version (24K): [in a new window] |
FIG. 3. VP4, the spike protein of rotavirus, is present in the DRM fraction. Caco-2 cells infected with rotavirus (10 PFU/cell) were treated with 1% Triton X-100 on ice 18 h p.i., and DRM were floated on a sucrose gradient as described in Materials and Methods. Twelve fractions were collected, fraction 1 representing the top of the gradient. Aliquots of each fraction were precipitated with TCA, and the distribution of rotavirus VP4 and AP along the gradient was assayed by immunoblotting.
|
|
View this table: [in a new window] |
TABLE 1. Cholesterol and sphingomyelin content of DRM from Caco-2 cells is not modified by rotavirus infectiona
|
![]() View larger version (21K): [in a new window] |
FIG. 4. HPLC profile of glycerophospholipid molecular species in the total membrane and DRM from Caco-2 cells. The glycerophospholipids isolated from total membranes or DRM of Caco-2 cells were treated with phospholipase C, and the diglycerides obtained were benzoylated as described in Materials and Methods. These derivatives were analyzed by HPLC using an RP-C18 column and a mixture of acetonitrile-isopropan-2-ol (75/25 [vol/vol]) and quantified through their absorption at 230 nm. Peak identification has been already described (38) and is reported on Table 2.
|
|
View this table: [in a new window] |
TABLE 2. Glycerophospholipid molecular species composition of rafts from Caco-2 cells is not modified by rotavirus infectiona
|
VP4 is enriched in Triton X-100-resistant membranes purified from infected Caco-2 cells. A significant part of VP4 was recovered in the pellet from the sucrose gradient together with AP. This pellet also contained large amounts of cholesterol and sphingomyelin. To improve the recovery of VP4 present in DRM, OptiPrep gradients were performed; this allowed flotation of most of the DRM fraction. VP4 contents in total-DRM and soluble fractions at different times p.i. were then compared. As shown in Fig. 5A, VP4 was present in DRM and soluble fractions from 6 h p.i. and its amount increased until 18 h p.i (Fig. 5B). Quantification of blots showed that the amount of VP4 associated with DRM was rather constant with time (40.5% ± 5.9%, n = 8). Since the DRM fraction contained about eightfold less protein than the soluble fraction, this corresponded to a fourfold VP4 enrichment in the DRM relative to the soluble fraction (Fig. 5C).
![]() View larger version (25K): [in a new window] |
FIG. 5. VP4 is present and enriched in the DRM fraction. Flasks of Caco-2 cells (25 cm2) were infected at 10 PFU/cell and incubated for different times p.i. Cells were then treated with Triton X-100, and DRM were prepared by flotation on an OptiPrep gradient. Fractions (1 ml) were collected. Fractions 4 and 5 accounted for the DRM fraction, and the bottom four fractions, containing 1% Triton X-100 and 40% OptiPrep, were pooled and accounted for the soluble fraction. (A) After TCA precipitation, 2% of the DRM (6.7 µg of protein) and 1% of the soluble fraction (48 µg of protein) were analyzed by Western blotting using an anti-VP4 antibody (monoclonal antibody 7.7). (B) Blots were quantified using Scion Image software. Black squares and white triangles, total amounts of VP4 in the soluble and DRM fractions, respectively. (C) Amounts of VP4 relative to the amounts of total protein present in soluble (black bars) and DRM (hatched bars) fractions at 18 h p.i.
|
![]() View larger version (17K): [in a new window] |
FIG. 6. Influence of virus protein VP4 on the phase behavior of a model lipid mixture. The lipid mixture used in these experiments contained phosphatidylethanolamine-phosphatidylserine-sphingomyelin-cholesterol (50/17/15/18 [mol/mol]). Lipids were fully hydrated at pH 8 in the presence of calcium (1 cation/100 lipids). (A) The lipid mixture adopts an inverted-hexagon arrangement characterized by a periodicity of 6.4 nm between 10 and 45°C. A trace of Pn3m-type cubic phase is detected in the small-angle area at the highest temperatures recorded. (B) In the presence of VP4 the lamellar phase (repeat distance, 6.45 nm) is preferred. Above 37°C the lamellar arrangement coexists with an inverted-hexagon phase (repeat distance, 6.31 nm).
|
![]() View larger version (43K): [in a new window] |
FIG. 7. The other virus structural proteins appeared progressively in the DRM fraction. Soluble (Sol) and DRM fractions were prepared as for Fig. 5 and were compared to crude homogenates (Ho). (A) Virus proteins detected by Western blotting using a polyclonal anti-RF antibody in total-homogenate, DRM, and soluble fractions at 6, 12, 15, and 18 h p.i. (note that the amounts of the samples loaded on the gel represented 0.5, 4, and 0.45% of total-homogenate, DRM, and soluble fractions, respectively, and that these values were used to normalize the percentages calculated for panel C). VP4, VP6, and VP7 are indicated. (B) VP2 was detected by Western blotting using a monoclonal anti-VP2 antibody. (note that the amounts of the samples loaded on the gel represented 0.5, 4, and 0.9% of total-homogenate, DRM, and soluble fractions, respectively, and that these values were used to normalize the percentages calculated for panel C). (C) Blots were quantified and normalized, and results (mean ± standard deviations of two independent determinations) are expressed as percentages of the viral proteins in the DRM fraction compared to their total amounts in whole-cell homogenate. White, light gray, medium gray, and dark gray bars, VP4, VP2, VP6, and VP7, respectively.
|
![]() View larger version (39K): [in a new window] |
FIG. 8. Rafts prepared from infected cells contain infectious viral particles. (A) Quantification of virus-associated particles along the sucrose gradient. Caco-2 cells were infected at 10 PFU/cell and were collected 24 h p.i. Whole-cell homogenates were subjected to a sucrose gradient as described in Materials and Methods. Fractions were collected, and the rotavirus titer in each fraction was determined as previously described (40). The data are representative of three independent experiments. (B) Caco-2 cells were infected at 10 PFU/cell and were collected 24 h p.i. DRM were purified by flotation from these infected cells and used to infect MA 104 cells, which were screened by indirect IF for the presence of rotavirus using an anti-RF antibody and a secondary FITC-labeled anti-rabbit IgG antibody. Nuclei were stained with propidium iodide.
|
![]() View larger version (18K): [in a new window] |
FIG. 9. Influence of virus particles on the phase behavior of a model lipid mixture. The lipid mixture used in these experiments contained phosphatidylethanolamine-phosphatidylserine-sphingomyelin-cholesterol (4/1/2/2 [mol/mol]). Lipids were fully hydrated in the presence of calcium (1 cation/1,000 lipids). (A) The quaternary mixture retains a single inverted hexagonal phase between 14 and 45°C (heating temperature scan rate, 2°C/min). The diffraction peaks point to the repeat distance (d) of 6.23 nm, with a second-order signal corresponding to the periodicity d:d/1:d/2: ... . (B) When viral particles are added to the previous lipid mixture, the phase is changed to a single lamellar arrangement characterized by a repeat distance of 6.77 nm (6.77/3.41 for the periodicity 1/[1/2]).
|
![]() View larger version (22K): [in a new window] |
FIG. 10. Nonstructural protein NSP4 is associated with rafts at 18 h p.i. The soluble fraction and DRM were prepared as for Fig. 5. Two percent of the DRM and 0.5% of the soluble fraction were loaded on the gel. NSP4 was detected by Western blotting using a polyclonal anti-NSP4 antibody.
|
|
|
|---|
How does VP4 interact with rafts? One of the most striking results of the present work is the demonstration that VP4, a cytosolically synthesized protein, directly interacts with lipid microdomains. An increasing number of proteins, including viral proteins, have been shown to interact with rafts, mostly through their transmembrane domains (32, 39, 54). It has also been shown that another viral protein reversibly associates with rafts through covalent lipid modifications, namely, poliovirus capsid protein VP4, whose myristoylation is responsible for its targeting to DRM (37). Although there are potential consensus sites for rotavirus VP4 acylation, this protein has never been shown to be acylated in vivo. This strongly suggests that VP4 should associate with rafts in an alternative way since this protein interacts directly but does not exhibit an obvious transmembrane domain or a GPI anchor and is not glycosylated (61). VP4 is a 776-amino-acid (aa) protein that presents some well-characterized signatures: a fusogenic domain (aa 383 to 405), a coiled-coil domain (aa 494 to 516), an integrin-interacting domain (aa 302 to 315), and a caveolin binding consensus sequence (aa 287 to 296). Recent data suggest that the fusogenic domains of viral proteins may be involved in in vitro interactions with membrane lipid models (25, 57). In line with these suggestions, it has been shown that VP4, together with VP7, promotes membrane fusion of virus with liposomes (45) and that VP4 is responsible for cell fusion from without through its fusogenic domain (15, 21). However, these observations point to a role of the fusogenic domain in rotavirus entry, i.e., a passage through the membrane rather than a simple interaction with membranes. VP4 also exhibits a caveolin binding domain (aa 287 to 296), which is a good candidate for interactions with rafts. However, since Caco-2 cells do not express caveolins (40), the involvement of this domain in our model seems to be unlikely. A final possibility is that VP4 interacts with rafts through its VP8* component, which is located on the N-terminal part of the molecule, oriented toward the exterior of the particle (13, 70). Interestingly it has been reported very recently that VP8* contains a galectin-like domain (P. R. Dormitzer, Z. Y. J. Sun, H. B. Greenberg, G. Wagner, and S. C. Harrison, Abstr. 20th Annu. Meet. Am. Soc. Virol., abstr. W 15-1, 2001), a result reminiscent of data indicating that several viruses that display a hemagglutinin domain, such as rotavirus VP4, have a lectin domain (10, 56, 65). Therefore it is possible that the lectin-like domain of VP8* carries a raft-interacting function, as already proposed for cellular glycoproteins en route to the apical membrane (16). Further experiments are needed to delineate if direct interaction of VP4 with sphingolipid-cholesterol-rich membranes and/or with glycosphingolipids is involved in rotavirus-raft interactions.
Where may VP4 interact with rafts? It is assumed that rafts play a key role in apical targeting in epithelial cells (58). Our results clearly demonstrate that VP4 association with rafts and its apical targeting are two related events. An unresolved aspect of this conclusion is to understand where a protein known to be synthesized in the cytoplasm may interact with rafts. After its cytoplasmic synthesis VP4 may associate with rafts already present on the apical plasma membrane. However it is not clear why VP4 specifically prefers the apically located microdomains. One possible explanation may rely on the fact that the lipid compositions of the apical and the basolateral domains are different (33, 64). We favor a second hypothesis, in which, after its synthesis in the cytoplasm, VP4 may rapidly attach to intracellular membranes en route to the apical surface. Interestingly such a mechanism has recently been proposed for a family of cellular cytosolic proteins named galectins, which, as already shown for rotavirus (30), reach the cell membrane through an atypical route bypassing the Golgi (26). More interestingly galectin 4, a member of this family, has been shown to reach the apical membrane of polarized cells through a Golgi-bypassing pathway thanks to its association with rafts (24). Since the VP8* core contains a galectin-like domain (Dormitzer et al., 20th Annu. Meet. Am. Soc. Virol.), it is tempting to speculate that VP4 may follow a pathway similar to the one described for galectin 4. If this mechanism holds true in Caco-2 cells, then it remains to find out the subcellular origin of rafts with which VP4 associates. In eucaryotic cells, rafts cannot be synthesized in the ER because of the lack of sphingolipid synthesis in this compartment, by contrast with yeasts, in which ER rafts have been characterized (43). It is assumed that rafts emerge from the Golgi and/or the trans-Golgi network (42), a location where neither VP4 nor entire rotavirus was detected (22, 30). Further studies are needed to define the precise origin of rafts that interact with VP4. These rafts may either derive from the retrograde transport between the Golgi apparatus and the ER or be part of another organelle located in the vicinity of the ER.
What are the consequences of our finding for rotavirus assembly? The present results are consistent with the view that rotavirus interacts with rafts through its spike protein, VP4, and suggest that these microdomains act as a platform for virus final assembly. The delayed association of other rotavirus structural proteins and the presence of NSP4 within rafts at the time of virus assembly strongly argue for such a mechanism. The fact that the proportions of virus structural proteins in rafts, except for VP4, remain low is also in agreement with the fact that virus assembly is a transient phenomenon, which is rapidly followed by the dissociation of mature viruses from the rafts and their secretion. In the classical model of rotavirus assembly, it is assumed that the whole process takes place into the ER. How may rafts play a role since until now no raft in the ERs of mammalian cells has been described? This question leads us to propose a new model of rotavirus assembly in which the final part of the process, namely, VP4 incorporation into preformed particles, takes place in an extrareticular location. Rafts then provide a platform that already contains VP4 and that upon NSP4 attachment incorporates VP7 and the other structural proteins. The present results favor this later view, and current investigations are dedicated to the identification of the compartment that contains rafts and that will interact with the ER to accomplish this final assembly step.
We thank Hans Peter Hauri, Suzanne Maroux, and John Taylor for providing antibodies. Annie Charpilienne was present throughout the work, and her kind help with rotavirus technologies was very useful. Philippe Fontanges took care of the confocal microscope, which gave us many interesting pictures. Thanks to Karine Gherdi for secretarial work.
This work was supported by grants from the research ministry of France (PRFMMIP), institutional funds from INSERM and Université Pierre et Marie Curie (Paris VI, France), and grants from the FRM (IC.34 to G. Trugnan) and ARC (no. 9367 to G. Trugnan).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»